Form 8-K - Current report:
SEC Accession No. 0001140361-18-036732
Filing Date
2018-08-21
Accepted
2018-08-21 08:07:08
Documents
3
Period of Report
2018-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 27479
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 11305
3 image00001.jpg GRAPHIC 3586
  Complete submission text file 0001140361-18-036732.txt   45115
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 181029528
SIC: 2834 Pharmaceutical Preparations